Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 168   

Articles published

GSK 1,464.50 +14.00 (0.97%)
price chart
Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or ...
GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) are similar businesses, but if you could only pick one then choosing between the two is difficult.
As Bioquell plc Surges, Should You Dump It To Invest In GlaxoSmithKline plc?
Bioquell (LSE: BQE) announced today that it was looking for partners - inevitably, the stock rose more than 8% on the day, after an already impressive rally (+45%) so far this year.
What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Royal ...
Top FTSE 100 pharmaceuticals firm GlaxoSmithKline still does blockbuster drugs, but Merchants likes the way the company has been consolidating its global leadership positions in vaccines and consumer health, where there are “scale advantages” and ...
5 Dividend Darlings Delivering Jaw-Dropping Returns: GlaxoSmithKline plc ...
Fears over the financial robustness of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) were fanned in Wednesday business after it announced it was scrapping plans to return �4bn worth of cash to shareholders following its asset-swap with Novartis.
Beat A Volatile FTSE 100 With GlaxoSmithKline plc, Smith & Nephew plc, WPP ...
While the FTSE 100 gained a boost from the Conservative election victory, its medium-term outlook may be somewhat uncertain. That's because, while the UK economy is performing well, the EU referendum could take place next year and, between now and ...
Brokerages Set GlaxoSmithKline plc Price Target at $52.00 (NYSE:GSK)  sleekmoney
GlaxoSmithKline PLC Price Target Update  The Daily Rover
GlaxoSmithKline plc Earns "Hold" Rating from Berenberg Bank (GSK)
Shares of GlaxoSmithKline plc (NYSE:GSK) opened at 45.26 on Friday. GlaxoSmithKline plc has a 1-year low of $41.25 and a 1-year high of $55.29.
GlaxoSmithKline plc's Underperform Rating Reiterated at Credit Suisse (GSK)  sleekmoney
GlaxoSmithKline plc's "Underperform" Rating Reiterated at ...  Mideast Time
GlaxoSmithKline plc Pleases The Market With New Strategic 5-Year Plan
GlaxoSmithKline (LSE: GSK) released its results for the first quarter today and the company also issued a strategic update.
GlaxoSmithKline plc 19.1% Potential Upside Indicated by Barclays Capital  DirectorsTalk Interviews
Does GlaxoSmithKline plc's Latest Treatment Point To Its Future?  Yahoo Finance UK
3 Shares With Terrific Growth Prospects: GlaxoSmithKline plc, Unilever plc And ...
It is true that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) - like much of the pharmaceuticals sector - could be considered a risky pick for those seeking copper-bottomed growth prospects.
5 Stocks David Cameron Should Consider Buying: GlaxoSmithKline plc, BP plc ...
Andrew Witty, chief executive of GlaxoSmithKline, is one of the chosen few, so it would seem logical for Mr Cameron to consider buying shares in the pharmaceuticals giant.
Why GlaxoSmithKline plc Is More Attractive Than HSBC Holdings plc
By traditional valuation ratios HSBC Holdings (LSE: HSBA) looks cheaper than GlaxoSmithKline (LSE: GSK), but there is more to successful long-term investing than buying the cheapest-looking shares.